marzaa
Recombinant proteinexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Dec 18, 2017 (NCT03407651)
Timeline
Indications
Mechanism of action
- Coagulation factor VIISupplementation
F7 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04548791 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2020 | Catalyst Biosciences |
| NCT04489537 | Phase 3 | Nov 30, 2020 | Catalyst Biosciences |
| NCT04072237 | Phase 1 | Sep 30, 2019 | Catalyst Biosciences, Sponsor GmbH |
| NCT03407651 | Phase 2 | Dec 18, 2017 | Catalyst Biosciences |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Catalyst Biosciences | For profit | 4 | 4 | 3 | 2017 |
| Sponsor GmbH | Academic/Hospital | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1